Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab continuation versus withdrawal for maintenance of remission in non-radiographic axial spondyloarthritis
NL-OMON41245Phase 4Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Aug 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in non-radiographic axial spondyloarthritis (nr-axSpA), sponsored by AbbVie Inc.. Started Aug 2013; status: active, not recruiting.
02
Drugs
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NL-OMON41245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41245.